<DOC>
	<DOCNO>NCT00003235</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Radiation therapy use high-energy x-rays damage tumor cell . Combining one drug either standard radiation therapy radiation therapy give different time may kill tumor cell . PURPOSE : Randomized phase III trial compare effectiveness combination chemotherapy consist paclitaxel carboplatin , plus either standard radiation therapy radiation therapy give different time , treat patient stage III non-small cell lung cancer surgically remove .</brief_summary>
	<brief_title>Combination Chemotherapy Plus Radiation Therapy Treating Patients With Stage III Non-small Cell Lung Cancer That Can Not Be Surgically Removed</brief_title>
	<detailed_description>OBJECTIVES : I . Determine response rate , duration response , survival patient unresectable regionally advanced ( M0 ) stage IIIA IIIB non-small cell lung carcinoma treat induction paclitaxel carboplatin follow conventional v accelerate radiation . II . Evaluate pattern local distant failure patient treat regimen . OUTLINE : Patients stratify histology ( squamous vs nonsquamous ) , performance status ( 0 vs 1 ) , disease stage ( IIIA v IIIB ) , response induction chemotherapy ( initial response v response ) . All patient receive induction therapy consist paclitaxel IV 3 hour follow carboplatin IV 30 minute day 1 22 . Treatment repeat every 42 day 2 course . Patients whose disease progress outside thorax randomize 1 2 treatment arm . Arm I : Patients receive standard radiotherapy day , 5 day week 6-7 week . Arm II : Patients receive hyperfractionated accelerated radiotherapy 3 time daily , 5 day week 2.5 week . Each fraction separate minimum 4 hour . Radiotherapy begin day 43 50 . Patients follow 1 month radiotherapy , every 3 month 2 year , every 6 month next 3 year , annually thereafter . PROJECTED ACCRUAL : Approximately 294 patient accrue study within 3.5 year .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Paclitaxel</mesh_term>
	<mesh_term>Albumin-Bound Paclitaxel</mesh_term>
	<mesh_term>Carboplatin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm unresectable stage IIIA IIIB nonsmall cell carcinoma lung Adenocarcinoma Squamous cell carcinoma Anaplastic large cell carcinoma Stage IIIA patient must candidate resection neoadjuvant therapy ( unresectable T3N1 T13 primary tumor metastasis limit ipsilateral mediastinal subcarinal lymph node ) Mediastinotomy thoracoscopy require potentially resectable IIIa disease ipsilateral mediastinal lymph node le 2 cm Stage IIIB patient must significant pleural effusion ( see CT scan OR reaccumulate one thoracentesis cytologically negative ) Metastases contralateral mediastinal supraclavicular node allow Measurable evaluable disease No distant metastasis significant pleural effusion PATIENT CHARACTERISTICS : Age : 18 Performance status : ECOG 01 Life expectancy : At least 12 week Hematopoietic : WBC least 3,500/mm3 Platelet count least 100,000/mm3 Granulocyte count least 1,500/mm3 Hemoglobin least 10 g/dL Hepatic : Bilirubin le 1.5 mg/dL SGOT great 2 time normal No liver disease significant hepatic insufficiency Renal : Creatinine great 1.5 mg/dL OR Creatinine clearance least 50 mL/min Cardiovascular : No cardiac arrhythmia end stage congestive heart failure Neurologic : No preexist clinically significant peripheral neuropathy No organic brain syndrome Other : No history prior concurrent malignancy past 5 year except : Surgically cure basal cell carcinoma skin Carcinoma situ cervix Not pregnant Fertile patient must use effective contraception 2 week study PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior systemic chemotherapy Endocrine therapy : Not specify Radiotherapy : No prior thoracic radiotherapy Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>squamous cell lung cancer</keyword>
	<keyword>large cell lung cancer</keyword>
	<keyword>stage IIIA non-small cell lung cancer</keyword>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>adenocarcinoma lung</keyword>
</DOC>